Diagnose newborns with sickle cell disease and enter one and not more than
ten. Maintain adequate retention and follow-up of patients. Perform
routine "steady state" visits on CSSCD patients as outlined in the protocol.
Continue the collection of special tests to measure organ damage. Continue
the collection of data on all acute and chronic events. Initiate the
psychosocial protocol with a randomized set of patients as identified by
the Statistical Coordinating Center. Continue the collection and shipping
of blood samples for specific centralized determinations.
No Sub Projects information available for N01HB072996-020
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for N01HB072996-020
Patents
No Patents information available for N01HB072996-020
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for N01HB072996-020
Clinical Studies
No Clinical Studies information available for N01HB072996-020
News and More
Related News Releases
No news release information available for N01HB072996-020
History
No Historical information available for N01HB072996-020
Similar Projects
No Similar Projects information available for N01HB072996-020